Sha-sha JIANG, Yong-fu PAN, Mo YANG, et al. Effect of Danggui Shaoyao San Drug-containing Serum on Expression of p-MLCⅡ and MLCⅡ Protein in HSC-T6 Cells Induced by ET-1[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(2): 14-19.
DOI:
Sha-sha JIANG, Yong-fu PAN, Mo YANG, et al. Effect of Danggui Shaoyao San Drug-containing Serum on Expression of p-MLCⅡ and MLCⅡ Protein in HSC-T6 Cells Induced by ET-1[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(2): 14-19. DOI: 10.13422/j.cnki.syfjx.20190226.
Effect of Danggui Shaoyao San Drug-containing Serum on Expression of p-MLCⅡ and MLCⅡ Protein in HSC-T6 Cells Induced by ET-1
To investigate the effect of endothelin-1 (ET-1) on the expression of phosphorylated myosin light chain Ⅱ(p-MLCⅡ)and myosin light chain Ⅱ(MLCⅡ)protein in rat hepatic stellate cells HSC-T6 and explore the intervention effect of Danggui Shaoyao San(DSS)drug-containing serum.
Method:
2
After HSC-T6 cells were seeded
DMEM and blank rat serum with final concentrations of 2.5%
5%
10%
15% and 20% were added to each well. The viability of HSC-T6 cells was determined by methyl thiazolyl tetrazolium(MTT) assay to screen the suitable serum concentration range. The cells were divided into blank serum control group (5%
10%
15%) and DSS drug-containing serum group (5%
10%
15%). ELISA was used to detect the content of ET-1 in cell culture supernatant under basic state. The cells were divided into blank serum control group (10%)
DSS drug-containing serum low (5%)
medium (10%) and high dose (15%) groups. Real-time fluorescent quantitative polymerase chain reaction (Real-time PCR) was used to detect the level of ET-1 mRNA in cell culture supernatant under basic state. The cells were divided into blank serum control group (10%)
model group (10%)
DSS drug-containing serum low (5%)
medium (10%)
high dose (15%) groups and Y-27632 inhibitor group (100 μmol·L
-1
). Except the blank serum control group
the other groups all received 10 nmol·L
-1
ET-1 to induce HSC-T6 cells. Western blot was used to detect the expression of p-MLCⅡ and MLCⅡ in HSC-T6 cells induced by ET-1.
Result:
2
Serum concentrations of 5%
10% and 15% were used as drug-containing serum concentrations. As compared with the blank serum control group
the DSS drug-containing serum group significantly reduced the relative content of ET-1 and ET-1 mRNA in the basic state (
P
<
0.05
P
<
0.01). As compared with the blank serum control group
the expression of p-MLCⅡ and MLCⅡ protein in the model group was significantly increased (
P
<
0.01); DSS drug-containing serum groups and Y-27632 inhibitor group can significantly down-regulate p-MLCⅡ and MLCⅡ protein expression (
P
<
0.05
P
<
0.01).
Conclusion:
2
DSS drug-containing serum may down-regulate the expression of p-MLCⅡ and MLCⅡ by down-regulating the content of ET-1 and inhibiting the autocrine of ET-1.
Schepis F , Turco L , Bianchini M , et al . Prevention and management of bleeding risk related to invasive procedures in cirrhosis [J]. Semin Liver Dis , 2018 , 38 ( 3 ): 215 - 229 .
Khimji A K , Rockey D C. Endothelin and hepatic wound healing [J]. Pharmacol Res , 2011 , 63 ( 6 ): 512 - 518 .
Rodríguez-Pascual F , Busnadiego O , González-Santamaría J. The profibrotic role of endothelin-1:is the door still open for the treatment of fibrotic diseases [J]. Life Sci , 2014 , 118 ( 2 ): 156 - 164 .
JI H , MENG Y , ZHANG X , et al . Aldosterone induction of hepatic stellate cell contraction through activation of RhoA/ROCK-2 signaling pathway [J]. Regul Pept , 2011 , 169 ( 1/3 ): 13 - 20 .
SHI M , WEI J , MENG W Y , et al . Effects of phased joint intervention on Rho/ROCK expression levels in patients with portal hypertension [J]. Exp Ther Med , 2016 , 12 ( 3 ): 1618 - 1624 .
ZHANG C G , ZHANG B , DENG W S , et al . Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl 4 -induced liver cirrhosis [J]. World J Gastroenterol , 2016 , 22 ( 18 ): 4484 - 4500 .
Sakamoto Y , Sakai M , Watari T. Hepatic and plasma endothelin-1 in dogs with chronic hepatitis [J]. J Vet Intern Med , 2017 , 31 ( 3 ): 764 - 769 .
Klein S , Rick J , Lehmann J , et al . Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis [J]. Gut , 2017 , 66 ( 1 ): 145 - 155 .
Thabut D , Shah V. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease:new targets for the treatment of portal hypertension [J]. J Hepatol , 2010 , 53 ( 5 ): 976 - 980 .
Kisseleva T , Brenner D A. Hepatic stellate cells and the reversal of fibrosis [J]. J Gastroenterol Hepatol , 2006 , 21 ( 3 ): S84 - S87 .
Rockey D . The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin,and nitric oxide [J]. Hepatology , 1997 , 25 ( 1 ): 2 - 5 .
FAN M , SU C , LU L , et al . Ultrasonic diagnosis and vasoactive substances examination in patients with cirrhosis [J]. Asian Pac J Trop Med , 2014 , 7 ( 4 ): 329 - 332 .
Rockey D C , Fouassier L , Chung J J , et al . Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells [J]. Hepatology , 1998 , 27 ( 2 ): 472 - 480 .
Sward K , Dreja K , Susnjar M , et al . Inhibition of Rho-associated kinase blocks agonist-induced Ca 2+ sensitization of myosin phosphorlation and force.in guinea pig ileum [J]. J Physiol , 2000 , 522 ( 1 ): 33 - 49 .
Bi D , Nishimura J , Niiro N , et al . Contraetile properties of the cultured vaseular smooth musele cells: the crueial role played by rhoA in the regulation of contraetility [J]. Cire Res , 2005 , 96 ( 8 ): 890 - 897 .
Hersch E , HUANG J , Grider J R , et al . Gq/G13 signaling by ET-1 in Smooth muscle: MYPT1 phosphorylation via ETA and CPI-17 dephosphorylation via ETB [J]. Am J Physiol Cell Physiol , 2004 , 287 ( 5 ): C1209 - C1218 .
SONG J , LU Y P , LUO G H , et al . Effects of mycophenolate mofetil on chronic allograft nephropathy by affecting RHO/ROCK signal pathways [J]. Transplant Proc , 2008 , 40 ( 8 ): 2790 - 2794 .
Screening Methods for Optimal Serum Concentration of Chinese Medicine: A Review
Effect of Yiqi Jiedu Prescription-containing Serum on Proliferation of mTEC and Regulatory T Cells in Myasthenia Gravis Patients with Thymus Hyperplasia
Effect of Drug-containing Serum of Clerodendrum bungei on Liver Cancer Cells Through PI3K/Akt Signaling Pathway
The Protective Effect of Yi-Xin-Kang Capsule-containing Serum on the Activity of H-ATP Ase in Myocardial Mitochondria Injured by Oxygen Stress in Rats
Study I on Substance Basis and Mechnaism of Action of Danggui Shaoyao San in the Prevention and Treatment of Senile Dementia-Cooperative and Selective Actions in the Prescription
Related Author
LIN Taoxiu
ZHANG Wenjuan
ZHANG Yuejian
SUN Xinhui
HUO Chaoyue
HE Tiantian
MA Xiaona
Sen-lin CHEN
Related Institution
Beijing University of Chinese Medicine Third Affiliated Hospital
Guizhou University of Traditional Chinese Medicine(TCM)
The Second Affiliated Hospital of Guizhou University of TCM